J Am Coll Cardiol March 2022 PMID 35210031

Lipoprotein(a) and Coronary Calcium: Clinical Management and Potential Design of Primary Prevention Trials.

Sotirios Tsimikas

Download social card

Mentions

43
Peak: 32 in Feb 2022
across 3 sources since Feb 2022

Extended reach

846,309
potential audience

Total likes

9,807

Video views

637,677

Mentions per month

Feb 2022 – Jul 2023

Where it's discussed

  • X / Twitter36 posts
  • News5 articles
  • YouTube2 videos

AI synopsis

What people are saying

The discussions highlight the significance of the article by referencing key studies like Mehta et al. and editorial comments from experts such as Dr. Tsimikas, which convey a sense of enthusiasm and importance. The tone varies from supportive to analytical, emphasizing that the publication could shape future prevention trials and clinical decisions related to lipid and calcium markers.

AgreementModerate agreement

Most discussions support the importance of the research, referencing studies and experts positively.

InterestHigh interest

Posts show high enthusiasm for new findings, emphasizing the relevance of lipoprotein(a) and coronary calcium in risk assessment.

EngagementModerate engagement

Users actively share links, comment on studies, and mention editorial insights, indicating meaningful engagement.

ImpactModerate impact

The discussions reflect a recognition of the potential influence on clinical practice, particularly in prevention strategies.

Abstract in brief

  • This text discusses the role of lipoproteins (like LDL cholesterol) and coronary calcium in assessing the risk of heart disease, focusing on how they can help guide clinical decisions for preventing heart attacks.
  • It reviews current strategies for managing patients based on lipid levels and coronary artery calcification, aiming to improve prevention methods for high-risk individuals.
  • The article also explores how future prevention trials might be designed, considering these markers to better evaluate new treatments and interventions for reducing coronary artery disease.]

Top posts

Most liked on X and Bluesky
Sam Tsimikas, MD
@Lpa_Doc · X

Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated Lp(a) and CAC in MESA and DHS. See my take and how a primary prevention CVOT might be performed. https://t.co/OiqsaRMaVE https://t.co/TSeS8ZcN3v https://t.co/ZVx9q8d3Qp

Feb 21, 2022 · 100 likes · 27 shares · 14,402 followers View post →
Sam Tsimikas, MD
@Lpa_Doc · X

Clarification, CAC=0 generally has excellent prognosis for short term risk. For high Lp(a), CAC=0 is not entirely protective, but risk is much lower than if CAC is >100. See my editorial on this. https://t.co/GNCMMJe7aP https://t.co/1deHK7zMp5

Feb 18, 2023 · 13 likes · 2 shares · 14,402 followers View post →
Nestor Vasquez
@NEVasquez92 · X

@MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t.co/yZzHRagidx

Feb 21, 2022 · 11 likes · 2 shares · 318 followers View post →
Teresa Arrobas Velilla
@TeresaArrobas · X

Lipoproteína(a) y calcio coronario: manejo clínico y diseño potencial de ensayos de prevención primaria.@sea_es https://t.co/6MDrZx6DWz

Mar 4, 2022 · 4 likes · 1 share · 1,215 followers View post →
J-P
@JohnPaulCorry · X

@Lpa_Doc https://t.co/0urwz63Sdq …If you are having issues with the original link, as I had. Thanks @Lpa_Doc

Feb 21, 2022 · 1 like · 847 followers View post →
Hany Ragy
@Hragy · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 80,422 followers View post →

All mentions

Revel Peters
@urbanlamb · X

@MattyParks12 @5MinuteBody i'm gonna start pasting lotsa links to real science seeing people seem to be unable to find the info and have zero critical thinking skills https://t.co/RigwLKD3Pm https://t.co/DScmG6wqw2 https://t.co/E53mun18co https://t.co/0Rc1FiUhvz

Jun 5, 2023 · 109 followers View post →
Sam Tsimikas, MD
@Lpa_Doc · X

Clarification, CAC=0 generally has excellent prognosis for short term risk. For high Lp(a), CAC=0 is not entirely protective, but risk is much lower than if CAC is >100. See my editorial on this. https://t.co/GNCMMJe7aP https://t.co/1deHK7zMp5

Feb 18, 2023 · 13 likes · 2 shares · 14,402 followers View post →
Cristobal Morales
@CristobMorales · X

RT @TeresaArrobas: Lipoproteína(a) y calcio coronario: manejo clínico y diseño potencial de ensayos de prevención primaria.@sea_es https:/…

Mar 4, 2022 · 1 share · 17,050 followers View post →
Teresa Arrobas Velilla
@TeresaArrobas · X

Lipoproteína(a) y calcio coronario: manejo clínico y diseño potencial de ensayos de prevención primaria.@sea_es https://t.co/6MDrZx6DWz

Mar 4, 2022 · 4 likes · 1 share · 1,215 followers View post →
CardioAcademic
@CardioAcademic · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 23, 2022 · 27 shares · 3,221 followers View post →
Akekaluk
@xgaluck · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 23, 2022 · 27 shares · 190 followers View post →
Abu Shoyeb, MD
@abushoyeb · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 708 followers View post →
mastigia
@ergonoatia · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 1,444 followers View post →
xuejingemily
@Jingxue64154654 · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 15 followers View post →
Joel "Heart Prevention" Kahn MD, FACC
@drjkahn · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 32,281 followers View post →
ErwingGurrola
@GurrolaErwing · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 166 followers View post →
GÜRKAN
@GRKAN48189372 · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 79 followers View post →
Rosario “Russ” Colombo, MD, FACC
@russcolombomd · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 1,365 followers View post →
Felice Gragnano
@FeliceGragnano · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 5,284 followers View post →
(Dr) Lorna Fiedler
@FiedlerLorna · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 479 followers View post →
Linda
@wordfinga · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 22, 2022 · 27 shares · 4,593 followers View post →
Alberto Cordero
@acorderofort · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 4,892 followers View post →
Dr. Luiz Silva
@DrLuizSilva1 · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 390 followers View post →
Jeremy S. Pollock
@bmorecardiology · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 1,620 followers View post →
Dr. Luiz Silva
@DrLuizSilva1 · X

RT @NEVasquez92: @MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t…

Feb 21, 2022 · 2 shares · 390 followers View post →
Daniel Ambinder, MD
@Dr_DanMD · X

RT @NEVasquez92: @MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t…

Feb 21, 2022 · 2 shares · 10,095 followers View post →
Juan Manuel Hernandez
@JuanmaHernande · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 283 followers View post →
Dr. Michael Alexander
@MichaelAlexandp · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 842 followers View post →
J-P
@JohnPaulCorry · X

@Lpa_Doc https://t.co/0urwz63Sdq …If you are having issues with the original link, as I had. Thanks @Lpa_Doc

Feb 21, 2022 · 1 like · 847 followers View post →
HUGO COLOMBO MD
@HCOLOMBO1958 · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 1,123 followers View post →
Dr Megan McCarthy
@HeartFit_NP · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 203 followers View post →
Nishant Shah, MD
@Nishant_ShahMD · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 2,109 followers View post →
JB Singh
@jbsingh1 · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 217 followers View post →
Gustavo Cortez
@Gustavo22205004 · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 439 followers View post →
Nestor Vasquez
@NEVasquez92 · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 318 followers View post →
Hany Ragy
@Hragy · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 80,422 followers View post →
Vasiliki Tsampasian
@justvick · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 626 followers View post →
Jay Khambhati
@JKhambhati · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 1,504 followers View post →
Aung Myat MD
@IamSpurs · X

RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…

Feb 21, 2022 · 27 shares · 3,460 followers View post →
Sam Tsimikas, MD
@Lpa_Doc · X

Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated Lp(a) and CAC in MESA and DHS. See my take and how a primary prevention CVOT might be performed. https://t.co/OiqsaRMaVE https://t.co/TSeS8ZcN3v https://t.co/ZVx9q8d3Qp

Feb 21, 2022 · 100 likes · 27 shares · 14,402 followers View post →
Nestor Vasquez
@NEVasquez92 · X

@MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t.co/yZzHRagidx

Feb 21, 2022 · 11 likes · 2 shares · 318 followers View post →